A top British stem cell scientist says the hype surrounding therapeutic cloning makes it difficult for more medically beneficial stem cell research to come to the forefront. Professor Austin Smith says cloning has limited potential for disease treatment, unlike ordinary stem cells taken from surplus IVF embryos and adult tissue, but is mistakenly seen as vital to all stem cell research.

Related Summaries